PB1861: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME

por Byalik, T., Kokosadze, N., Paramonova, E., Semichev, D., Odzharova, ?., Semenova, A., Tumyan, G., Osmanov, E., Byalik, T.
Publicado 2022

PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES

por Zotina, E., Zhelnova, E., Karimova, E., Grishina, E., Paramonova, E., Gagloeva, D., Baryakh, E., Misyurina, E.
Publicado 2022

PB2184: COURSE OF CORONAVIRUS INFECTION IN ONCOHEMATOLOGICAL PATIENTS IN THE POST-TRANSPLANT PERIOD

por Grishina, E., Gagloeva, D., Zhelnova, E., Karimova, E., Zotina, E., Paramonova, E., Baryakh, E., Misyurina, E.
Publicado 2022

P912: COVID19 SEVERITY AND THERAPEUTIC OPTIONS IN PATIENTS WITH MULTIPLE MYELOMA

por Karimova, E., Zhelnova, E., Baryakh, E., Yatskov, K., Zotina, E., Grishina, E., Paramonova, E., Gagloeva, D., Misyurina, E.
Publicado 2022